640 related articles for article (PubMed ID: 16877425)
41. Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.
Tzekov R
Doc Ophthalmol; 2005 Jan; 110(1):111-20. PubMed ID: 16249962
[TBL] [Abstract][Full Text] [Related]
42. Quantitative Fundus Autofluorescence in HCQ Retinopathy.
Greenstein VC; Lima de Carvalho JR; Parmann R; Amaro-Quireza L; Lee W; Hood DC; Tsang SH; Sparrow JR
Invest Ophthalmol Vis Sci; 2020 Sep; 61(11):41. PubMed ID: 32976563
[TBL] [Abstract][Full Text] [Related]
43. Comparison of screening procedures in hydroxychloroquine toxicity.
Marmor MF
Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
[TBL] [Abstract][Full Text] [Related]
44. The blood-retinal barrier in chloroquine retinopathy.
Raines MF; Bhargava SK; Rosen ES
Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1726-31. PubMed ID: 2759787
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography.
So SC; Hedges TR; Schuman JS; Quireza ML
Ophthalmic Surg Lasers Imaging; 2003; 34(3):251-8. PubMed ID: 12757106
[TBL] [Abstract][Full Text] [Related]
46. The Role of Multifocal Electroretinography in the Assessment of Drug-Induced Retinopathy: A Review of the Literature.
Dettoraki M; Moschos MM
Ophthalmic Res; 2016; 56(4):169-177. PubMed ID: 27351191
[TBL] [Abstract][Full Text] [Related]
47. Assessing chloroquine toxicity in RA patients using retinal nerve fibre layer thickness, multifocal electroretinography and visual field test.
Xiaoyun MA; Dongyi HE; Linping HE
Br J Ophthalmol; 2010 Dec; 94(12):1632-6. PubMed ID: 20935309
[TBL] [Abstract][Full Text] [Related]
48. Subjective and objective screening tests for hydroxychloroquine toxicity.
Cukras C; Huynh N; Vitale S; Wong WT; Ferris FL; Sieving PA
Ophthalmology; 2015 Feb; 122(2):356-66. PubMed ID: 25444344
[TBL] [Abstract][Full Text] [Related]
49. A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy.
Greenstein VC; Amaro-Quireza L; Abraham ES; Ramachandran R; Tsang SH; Hood DC
Doc Ophthalmol; 2015 Feb; 130(1):13-23. PubMed ID: 25502494
[TBL] [Abstract][Full Text] [Related]
50. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).
Marmor MF; Kellner U; Lai TY; Melles RB; Mieler WF;
Ophthalmology; 2016 Jun; 123(6):1386-94. PubMed ID: 26992838
[TBL] [Abstract][Full Text] [Related]
51. Comparison between multifocal ERG and C-Scan SD-OCT ("en face" OCT) in patients with a suspicion of antimalarial retinal toxicity: preliminary results.
Arndt C; Costantini M; Chiquet C; Afriat M; Berthemy S; Vasseur V; Ducasse A; Mauget-Faÿsse M
Doc Ophthalmol; 2018 Apr; 136(2):97-111. PubMed ID: 29536324
[TBL] [Abstract][Full Text] [Related]
52. Hydroxychloroquine retinopathy despite regular ophthalmologic evaluation: a consecutive series.
Bienfang D; Coblyn JS; Liang MH; Corzillius M
J Rheumatol; 2000 Nov; 27(11):2703-6. PubMed ID: 11093457
[TBL] [Abstract][Full Text] [Related]
53. Discrete arcs of increased fundus autofluorescence in retinal dystrophies and functional correlate on microperimetry.
Fleckenstein M; Charbel Issa P; Fuchs HA; Finger RP; Helb HM; Scholl HP; Holz FG
Eye (Lond); 2009 Mar; 23(3):567-75. PubMed ID: 18344954
[TBL] [Abstract][Full Text] [Related]
54. Localized retinal electrophysiological and fundus autofluorescence imaging abnormalities in maternal inherited diabetes and deafness.
Bellmann C; Neveu MM; Scholl HP; Hogg CR; Rath PP; Jenkins S; Bird AC; Holder GE
Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2355-60. PubMed ID: 15223817
[TBL] [Abstract][Full Text] [Related]
55. Fundus autofluorescence in a case of occult macular dystrophy.
Rasquin F; Van Nechel C; Cordonnier M
Bull Soc Belge Ophtalmol; 2009; (313):9-12. PubMed ID: 20108567
[TBL] [Abstract][Full Text] [Related]
56. Hydroxychloroquine retinopathy: A review of imaging.
Pandya HK; Robinson M; Mandal N; Shah VA
Indian J Ophthalmol; 2015 Jul; 63(7):570-4. PubMed ID: 26458473
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of Maculopathy in Patients Using Hydroxychloroquine.
Uğurlu A; Aslanova M; Cebeci Z; Kır Mercül N
Turk J Ophthalmol; 2019 Jun; 49(3):149-153. PubMed ID: 31245977
[TBL] [Abstract][Full Text] [Related]
58. Early detection of macular changes with multifocal ERG in patients on antimalarial drug therapy.
Nebbioso M; Grenga R; Karavitis P
J Ocul Pharmacol Ther; 2009 Jun; 25(3):249-58. PubMed ID: 19348599
[TBL] [Abstract][Full Text] [Related]
59. Sveinsson chorioretinal atrophy: the mildest changes are located in the photoreceptor outer segment/retinal pigment epithelium junction.
Jonasson F; Sander B; Eysteinsson T; Jörgensen T; Klintworth GK
Acta Ophthalmol Scand; 2007 Dec; 85(8):862-7. PubMed ID: 17683515
[TBL] [Abstract][Full Text] [Related]
60. Chloroquine and hydroxychloroquine retinopathy: how to follow affected patients.
Ruiz RS; Saatci OA
Ann Ophthalmol; 1991 Aug; 23(8):290-1. PubMed ID: 1952637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
